Conditions: Seasonal Allergic Rhinitis
Keywords: GRAZAX
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 107
Healthy volunteers: no

Brief summary:
To investigate the immunologic effects and safety of 60-day treatment of the Standardized Quality units (SQ) grass Sublingual immunotherapy (SLIT)-tablet in adult subjects with grass pollen-induced allergic rhinoconjunctivitis in a double-blind, placebo-controlled study.

Detailed description:

Arms:
arm 1: Grass tablet 75,000 Standardized Quality units Tablet (SQ-T) arm 2: Placebo

Interventions: intervention 1: Phleum pratense grass pollen allergen extract intervention 2: placebo
Intervention descriptions: intervention 1: Allergy Immunotherapy grass tablet 75,000 SQ-T given once daily over 60 days intervention 2: placebo tablet given once daily over 60 days

Protocol document: